reports
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and P...
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced two poster presentations highlighting data on CD388 at the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) conference, being held A...
Climb Channel Solutions Launches Partnership with Automox, Providing L...
Climb Channel Solutions Launches Partnership with Automox, Providing Leading Endpoint Management Solution to North American Partners EATONTOWN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announced the launch of a new partnership with Automox, a leading cloud-native IT automation endpoint management solution, now available to their North American partners. With the addition of Automox, Climb partners can provide customers the capabilities to ...
Ring Energy Announces Timing of First Quarter 2024 Earnings Release an...
Ring Energy Announces Timing of First Quarter 2024 Earnings Release and Conference Call THE WOODLANDS, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its first quarter 2024 earnings release and conference call. Ring plans to issue its first quarter 2024 earnings release after the close of trading on Monday, May 6, 2024. The Company has scheduled a conference call on Tuesday, May 7, 2024 at 11:00 a.m. ET to discuss its first quarter 2024 operational and financial results. To participate, interested p...
Cidara Therapeutics Reacquires Global Development and Commercial Right...
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million - $240 million private placement financing led by RA Capital Management with significant participation by Bain Capital Life Sciences as well as BVF Partners and Canaan Partners to fund Phase 2b clinical trial - CD388, which is active against all strains of influenza A and B, is being developed for pre-exposure prophylactic treatment - Company to host business strategy update conference call and webcast today at 4:30 PM ET ...
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma...
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical development and CMC costs over the next three years and an additional approximately $61 million in forecasted obligations through the patent life of rezafungin Cidara to further focus on advancing Cloudbreak development programs, including a planned IND filing for its lead oncology candidate, CBO421, as well a...
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quart...
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided an update on its corporate activities and product pipeline. “...
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, announced on April 17, 2024, that the Company received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq) advising the Company that its failure to timely file its Annual Report o...
Cidara Therapeutics Announces Reverse Stock Split
Cidara Therapeutics Announces Reverse Stock Split SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-20. The effective time of the reverse stock split will be 5 p.m. ET on April 23, 2024. The Company’s co...
- Jonathan Moreland
MHLD MAIDEN HOLDINGS LTD.
HNRG HALLADOR ENERGY CO.
HOO HERBALIFE NUTRITION LTD.
DLTR DOLLAR TREE INC.
CRK COMSTOCK RESOURCES INC.
LULU LULULEMON ATHLETICA INC
RAIL FREIGHTCAR AMERICA INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
GLQ CLOUGH GLOBAL EQUITY FUND
WDFC WD-40 COMPANY
AINC ASHFORD
BRT BRT APARTMENTS
ISDR ISSUER DIRECT CORP.
LOVE LOVESAC
CWEN CLEARWAY ENERGY INC. CLASS C
ORGO ORGANOGENESIS HOLDINGS (A)
HROW HARROW HEALTH INC.
LEGH LEGACY HOUSING CORP
REEMF RARE ELEMENT RESOURCES
AIM AIM IMMUNOTECH
DCTH DELCATH SYSTEMS
HGBL HERITAGE GLOBAL
NKTX NKARTA
EGLE EAGLE BULK SHIPPING
SOWG SOW GOOD INC.
PHX PANHANDLE OIL AND GAS INC
SMMT SUMMIT THERAPEUTICS INC
AUID IPSIDY INC.
FSBC FIVE STAR BANCORP
DERM JOURNEY MEDICAL CORP
LEE LEE ENTERPRISES INC
MPA BLACKROCK MUNIYIELD PENNSYLVANIA FD
FTHY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
TCBX THIRD COAST BANCSHARES INC
ASLE AERSALE CORP
AIKI AIKIDO PHARMA INC.
BUKS BUTLER NATIONAL CORP
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
NMAI NUVEEN MULTI-ASSET INCOME FUND
ACRV ACRIVON THERAPEUTICS INC
LSXMA LIBERTY SIRIUSXM GROUP
TISI TEAM INC.
CBSTF CANNABIST CO HOLDINGS INC.
TSVT 2SEVENTY BIO INC
ASGI ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
INTZ INTRUSION INC
PROP PRAIRIE OPERATING CO.
LGVN LONGEVERON INC
OCX ONCOCYTE CORPORATION
Climb Global Solutions Sets First Quarter 2024 Conference Call for May...
Climb Global Solutions Sets First Quarter 2024 Conference Call for May 2, 2024 at 8:30 a.m. ET EATONTOWN, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, will host a conference call on Thursday, May 2, 2024 at 8:30 a.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2024. The Company’s results will be reported in a press release prior to the call. Climb’s management...
Flexsteel Industries, Inc. to Announce Third Quarter 2024 Results on A...
DUBUQUE, Iowa--(BUSINESS WIRE)-- Flexsteel Industries, Inc. (NASDAQ:FLXS) (“Flexsteel” or the “Company”), one of the largest manufacturers, importers, and marketers of residential furniture products in the United States, announced today that it will issue its third quarter 2024 financial results after market close on Monday, April 29, 2024. A conference call and audio webcast with analysts and investors will be held on Tuesday, April 30, 2024, at 8:00 a.m. Central Time to discuss the results and answer questions. Live conference call: 833-816-1123 (domestic) or 412-317-0710 (international...
- Jonathan Moreland
NEOG NEOGEN CORPORATION
MHLD MAIDEN HOLDINGS LTD.
HNRG HALLADOR ENERGY CO.
HOO HERBALIFE NUTRITION LTD.
GOGO GOGO INC.
DLTR DOLLAR TREE INC.
CRK COMSTOCK RESOURCES INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
LULU LULULEMON ATHLETICA INC
AAOI APPLIED OPTOELECTRONICS INC.
RAIL FREIGHTCAR AMERICA INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
GLQ CLOUGH GLOBAL EQUITY FUND
BRT BRT APARTMENTS
VICI VICI PROPERTIES INC
STKS THE ONE GROUP HOSPITALITY INC.
ISDR ISSUER DIRECT CORP.
CWEN CLEARWAY ENERGY INC. CLASS C
ORGO ORGANOGENESIS HOLDINGS (A)
HROW HARROW HEALTH INC.
LEGH LEGACY HOUSING CORP
REEMF RARE ELEMENT RESOURCES
AIM AIM IMMUNOTECH
DCTH DELCATH SYSTEMS
HGBL HERITAGE GLOBAL
NKTX NKARTA
EGLE EAGLE BULK SHIPPING
SOWG SOW GOOD INC.
PHX PANHANDLE OIL AND GAS INC
SMMT SUMMIT THERAPEUTICS INC
FSBC FIVE STAR BANCORP
DERM JOURNEY MEDICAL CORP
LEE LEE ENTERPRISES INC
ACHR ARCHER AVIATION INC
FTHY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
TCBX THIRD COAST BANCSHARES INC
ASLE AERSALE CORP
AIKI AIKIDO PHARMA INC.
BUKS BUTLER NATIONAL CORP
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
NMAI NUVEEN MULTI-ASSET INCOME FUND
LSXMA LIBERTY SIRIUSXM GROUP
TISI TEAM INC.
CBSTF CANNABIST CO HOLDINGS INC.
TSVT 2SEVENTY BIO INC
ASGI ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
INTZ INTRUSION INC
PROP PRAIRIE OPERATING CO.
LGVN LONGEVERON INC
- Jonathan Moreland
MHLD MAIDEN HOLDINGS LTD.
HNRG HALLADOR ENERGY CO.
HOO HERBALIFE NUTRITION LTD.
GOGO GOGO INC.
DLTR DOLLAR TREE INC.
CRK COMSTOCK RESOURCES INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
LULU LULULEMON ATHLETICA INC
AAOI APPLIED OPTOELECTRONICS INC.
GLQ CLOUGH GLOBAL EQUITY FUND
BRT BRT APARTMENTS
VICI VICI PROPERTIES INC
FPF FIRST TRUST INTERMEDIATE DURATION PREFERRED AND INCOME FUND
STKS THE ONE GROUP HOSPITALITY INC.
ISDR ISSUER DIRECT CORP.
CWEN CLEARWAY ENERGY INC. CLASS C
ORGO ORGANOGENESIS HOLDINGS (A)
HROW HARROW HEALTH INC.
LEGH LEGACY HOUSING CORP
REEMF RARE ELEMENT RESOURCES
AIM AIM IMMUNOTECH
DCTH DELCATH SYSTEMS
HGBL HERITAGE GLOBAL
NKTX NKARTA
EGLE EAGLE BULK SHIPPING
CSU CAPITAL SENIOR LIVING
SOWG SOW GOOD INC.
PHX PANHANDLE OIL AND GAS INC
SMMT SUMMIT THERAPEUTICS INC
MYO MYOMO
FSBC FIVE STAR BANCORP
GRPH GRAPHITE BIO
CLOV INC.
XERS CLOVER HEALTH INV CORP
DERM XERIS BIOPHARMA HLDGS INC
LEE JOURNEY MEDICAL CORP
ACHR LEE ENTERPRISES INC
FTHY ARCHER AVIATION INC
TCBX FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
ASLE THIRD COAST BANCSHARES INC
BUKS AERSALE CORP
MEGI BUTLER NATIONAL CORP
NMAI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
OABI NUVEEN MULTI-ASSET INCOME FUND
TISI OMNIAB INC
CBSTF TEAM INC.
TSVT CANNABIST CO HOLDINGS INC.
ASGI 2SEVENTY BIO INC
INTZ ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
INTRUSION INC
Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conju...
Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024 - Multispecific CD73/PD-1 DFC demonstrates improved tumor reduction compared to PD-1 monotherapy in nonclinical study - CCR5-targeting DFC demonstrates potent efficacy in colorectal cancer mouse model - Late-breaking CBO421 data demonstrates improved efficacy compared to oleclumab in human triple-negative breast cancer cell lines SAN DIEGO, April 05, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (N...
- Jeff Robertson
Scaling Business Through Acquisitions & Development
Acquisitions are expected to remain a centerpiece of management’s three-pronged strategy to increase scale in the asset base, reduce outstanding debt, and ultimately position the company to return cash to shareholders. The Stronghold acquisition in 3Q22, followed by the Founders acquisition in 3Q23, added operational scale and inventory depth on the southern portion of the Central Basin Platform (CBP). Together with Ring’s Northwest Shelf (NWS) assets, the inventory provides a diverse set of hor...
Scale Computing Approved on Climb Channel Solutions’ OMNIA Partners/NC...
Scale Computing Approved on Climb Channel Solutions’ OMNIA Partners/NCPA and GSA Contracts EATONTOWN, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) announced the expansion of their OMNIA Partners/NCPA (National Cooperative Purchasing Alliance) and GSA contracts with the addition of Scale Computing, a market leader in edge computing, virtualization, and hyperconverged solutions, and strategic partner of Climb since 2020. Scale Computing is bringi...
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avalo’s recent acquisition of AVTX-009, an anti-IL-1β mAb, and up to $185 million private placement financing WAYNE, Pa. and ROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced the addition of multiple biotech leaders to its Board of Directors. The Avalo Board brings together a team with expertise spannin...
- Jonathan Moreland
MHLD MAIDEN HOLDINGS LTD.
HNRG HALLADOR ENERGY CO.
HOO HERBALIFE NUTRITION LTD.
GOGO GOGO INC.
DLTR DOLLAR TREE INC.
CRK COMSTOCK RESOURCES INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
CE CELANESE CORPORATION
BANC BANC OF CALIFORNIA INCORPORATED
HRTG HERITAGE INSURANCE HOLDINGS INC.
LULU LULULEMON ATHLETICA INC
AAOI APPLIED OPTOELECTRONICS INC.
GLQ CLOUGH GLOBAL EQUITY FUND
BRT BRT APARTMENTS
VICI VICI PROPERTIES INC
CDLX CARDLYTICS INC
TALO TALOS ENERGY INC.
STKS THE ONE GROUP HOSPITALITY INC.
ISDR ISSUER DIRECT CORP.
SKYE NEMUS BIOSCIENCE INC
ORGO ORGANOGENESIS HOLDINGS (A)
HROW HARROW HEALTH INC.
LEGH LEGACY HOUSING CORP
REEMF RARE ELEMENT RESOURCES
AIM AIM IMMUNOTECH
DCTH DELCATH SYSTEMS
HGBL HERITAGE GLOBAL
NKTX NKARTA
CSU CAPITAL SENIOR LIVING
GRNT GRANIT SKOPKE
SOWG SOW GOOD INC.
PHX PANHANDLE OIL AND GAS INC
SMMT SUMMIT THERAPEUTICS INC
MYO MYOMO
GRPH GRAPHITE BIO
CLOV INC.
IMRX CLOVER HEALTH INV CORP
XERS IMMUNEERING CORP
DERM XERIS BIOPHARMA HLDGS INC
LEE JOURNEY MEDICAL CORP
ACHR LEE ENTERPRISES INC
DCGO ARCHER AVIATION INC
QSI DOCGO INC
TCBX QUANTUM-SI INC
ASLE THIRD COAST BANCSHARES INC
MEGI AERSALE CORP
NMAI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
OABI NUVEEN MULTI-ASSET INCOME FUND
TISI OMNIAB INC
CBSTF TEAM INC.
TSVT CANNABIST CO HOLDINGS INC.
ASGI 2SEVENTY BIO INC
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
Avalo Reports 2023 Financial Results and Provides Business Updates
Avalo Reports 2023 Financial Results and Provides Business Updates Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment of $115.6 millionTopline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026Expected cash runway into 2027 WAYNE, Pa. and ROCKVILLE, Md., March 29, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and year-end financial results for 2023....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.